At an official ceremony in Singapore last year, Straumann, a global leader in regenerative, restorative and replacement dentistry, was presented with the 2010 Asia Pacific Frost & Sullivan Dental Implant Company of the Year Award. The award recognizes excellence in growth strategy, innovation in business processes, and leadership in customer value and market penetration; it is one of the best practices awards bestowed by Frost & Sullivan, the global growth consulting company.

Product innovation, world-class education and practice building strengthen Straumann’s leading position in Asia Pacific.

“This award recognizes the success of our Asia Pacific headquarters, which has been established in 2008,” said Frank Hemm, Senior Vice President of Straumann Asia Pacific. “Straumann has outperformed the global market over the past two years and has enjoyed market-share gains, particularly in the fast-growing China and South East Asia region. Our success is driven by innovative, differentiated and clinically proven products and technologies with Swiss quality.

With our strengthened sales and marketing structure, we provide additional services that focus on our customers’ needs in the region. World-class clinical education, patient education and practice building support have won us the confidence of dental professionals in the region.”

Straumann engages in a broad range of educational activities across all specializations, in cooperation with our worldwide academic partner organization, the International Team of Implantology ITI. Both Straumann and the ITI share the same passion for science-based product innovation and the highest standard of education with the aim of promoting quality of patient care in implant dentistry.

Straumann continues to invest in Asia Pacific to secure premier market position “In the recent economic downturn, Straumann invested against the trend, for example in the Asia Pacific region with the successful introduction of innovative products like Bone Level Implant, SLActive and Roxolid®, a smaller diameter implant suitable for Asians. Its range of differentiated and clinically proven products of superior quality has allowed Straumann to secure a strong premier market positioning and gain market share despite price differentiation and competition. Straumann has successfully secured a leading position in most Asia Pacific markets that it has entered,” commented Jennifer Lau, Industry Analyst at Frost & Sullivan.